Causal effects of the microbiota on immune-mediated diseases

被引:91
|
作者
Round, June L. [1 ]
Palm, Noah W. [2 ]
机构
[1] Univ Utah, Dept Pathol, Div Microbiol & Immunol, Sch Med, Salt Lake City, UT 84211 USA
[2] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA
关键词
MULTIPLE-SCLEROSIS PATIENTS; HUMAN GUT MICROBIOTA; MUCUS LAYERS; T-CELLS; DIVERSITY; BACTERIA; COLONIZATION; MODEL; EXPRESSION; MATURATION;
D O I
10.1126/sciimmunol.aao1603
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mammalian immune system has evolved in the presence of a complex community of indigenous microorganisms that constitutively colonize all barrier surfaces. This intimate relationship has resulted in the development of a vast array of reciprocal interactions between the microbiota and the host immune system, particularly in the intestine, where the density and diversity of indigenous microbes are greatest. Alterations in the gut microbiota have been correlated with almost every known immunological disease, but in most cases, it remains unclear whether these changes are a cause or effect of the disease or merely a reflection of epidemiological differences between groups. Here, we review recent efforts to demonstrate a causal role for the microbiota in health and disease, outline experimental advances that have made these studies possible, and highlight how changes in microbial composition may influence immune system function.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Immune-mediated skin diseases in the horse
    van Oldruitenborgh-Oosterbaan, MMS
    Goehring, LS
    PFERDEHEILKUNDE, 2001, 17 (04): : 346 - +
  • [42] Genetic background for immune-mediated diseases
    Vartdal, F
    ACTA ODONTOLOGICA SCANDINAVICA, 2001, 59 (04) : 212 - 215
  • [43] Lymphocyte proliferation in immune-mediated diseases
    Datta, Shrimati
    Sarvetnick, Nora
    TRENDS IN IMMUNOLOGY, 2009, 30 (09) : 430 - 438
  • [44] Refocusing Human Microbiota Research in Infectious and Immune-mediated Diseases: Advancing to the Next Stage
    Giovanni, Maria Y.
    Schneider, Johanna S.
    Calder, Thomas
    Fauci, Anthony S.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (01): : 5 - 8
  • [45] Immune monitoring and treatment in immune-mediated inflammatory diseases
    Femke van Wijk
    Marjolein de Bruin
    Helen Leavis
    Stefan Nierkens
    Nature Communications, 13
  • [46] Immune monitoring and treatment in immune-mediated inflammatory diseases
    van Wijk, Femke
    de Bruin, Marjolein
    Leavis, Helen
    Nierkens, Stefan
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [47] Causal association of metformin treatment with diverse immune-mediated inflammatory diseases: A Mendelian randomization analysis
    Liao, Zheng
    Su, Chenguang
    Li, Jian
    Liu, Jinlong
    MEDICINE, 2025, 104 (06)
  • [48] The immunomodulatory effects of estrogens Clinical relevance in immune-mediated rheumatic diseases
    Cutolo, Maurizio
    Brizzolara, Renata
    Atzeni, Fabiola
    Capellino, Silvia
    Straub, Rainer H.
    Puttini, Pier Carlo Sarzi
    NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES: TRANSLATION FROM BASICS TO CLINICS, 2010, 1193 : 36 - 42
  • [49] Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases
    Borchers, Andrea T.
    Leibushor, Naama
    Cheema, Gurtej S.
    Naguwa, Stanley M.
    Gershwin, M. Eric
    JOURNAL OF AUTOIMMUNITY, 2011, 37 (04) : 273 - 288
  • [50] Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases
    Manabe, Shun
    Nitta, Kosaku
    Nagata, Michio
    RECENT ADVANCES IN THE PATHOGENESIS AND TREATMENT OF KIDNEY DISEASES, 2018, 195 : 131 - 142